Unknown

Dataset Information

0

DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases.


ABSTRACT: CAG repeat expansion is the genetic cause of nine incurable polyglutamine (polyQ) diseases with neurodegenerative features. Silencing repeat RNA holds great therapeutic value. Here, we developed a repeat-based RNA-cleaving DNAzyme that catalyzes the destruction of expanded CAG repeat RNA of six polyQ diseases with high potency. DNAzyme preferentially cleaved the expanded allele in spinocerebellar ataxia type 1 (SCA1) cells. While cleavage was non-allele-specific for spinocerebellar ataxia type 3 (SCA3) cells, treatment of DNAzyme leads to improved cell viability without affecting mitochondrial metabolism or p62-dependent aggresome formation. DNAzyme appears to be stable in mouse brain for at least 1 month, and an intermediate dosage of DNAzyme in a SCA3 mouse model leads to a significant reduction of high molecular weight ATXN3 proteins. Our data suggest that DNAzyme is an effective RNA silencing molecule for potential treatment of multiple polyQ diseases.

SUBMITTER: Zhang N 

PROVIDER: S-EPMC8609077 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3421186 | biostudies-literature
| S-EPMC5855950 | biostudies-literature
| S-EPMC6700281 | biostudies-literature
| S-EPMC129321 | biostudies-literature
| S-EPMC5844350 | biostudies-literature
| S-EPMC3001072 | biostudies-literature
| S-EPMC3232215 | biostudies-literature
| S-EPMC3107122 | biostudies-literature
| S-EPMC5368221 | biostudies-literature
| S-EPMC6276831 | biostudies-literature